Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-09-08

FDA Approved: DALFAMPRIDINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA has approved a supplemental application for dalfampridine from Sun Pharmaceutical Industries, Inc. This approval updates the regulatory status of this g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dalfampridine (dalfampridine)

Snippet

SUPPL AP for DALFAMPRIDINE (DALFAMPRIDINE)